Abstract:Due to the rapid development of stem cell technology, there have been tremendous advances in molecular biological and pathological research, cell therapy as well as organoid technologies over the past decades. Advances in genome editing technology, particularly the discovery of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related protein 9 (Cas9), have further facilitated the rapid development of stem cell researches. The CRISPR-Cas9 technology now goes beyond creating single gene editing to enable the inhibition or activation of endogenous gene loci by fusing inhibitory (CRISPRi) or activating (CRISPRa) domains with deactivated Cas9 proteins (dCas9). These tools have been utilized in genome-scale CRISPRi/a screen to recognize hereditary modifiers that are synergistic or opposing to malady mutations in an orderly and fair manner, thereby identifying illness mechanisms and discovering novel restorative targets to accelerate medicinal discovery investigation. However, the application of this technique is still relatively rare in stem cell research. There are numerous specialized challenges in applying large-scale useful genomics approaches to differentiated stem cell populations. Here, we present the first comprehensive review on CRISPR-based functional genomics screening in the field of stem cells, as well as practical considerations implemented in a range of scenarios, and exploration of the insights of CRISPR-based screen into cell fates, disease mechanisms and cell treatments in stem cell models. This review will broadly benefit scientists, engineers and medical practitioners in the areas of stem cell research.

The Application of Genome-wide CRISPR-Cas9 Screens to Dissect the Molecular Mechanisms of Toxins

Integrating genome-wide CRISPR screens and in silico drug profiling for targeted antidote development

The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans

Design, performance, processing, and validation of a pooled CRISPR perturbation screen for bacterial toxins

Research progress in drug toxicology based on systems biology

Application of CRISPR/Cas9-based genome editing in ecotoxicology

The application of CRISPR genome editing technologies in the pathogenesis studies, diagnosis, prevention and treatment of infectious diseases

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

A systematic identification of multiple toxin-target interactions based on chemical, genomic and toxicological data.

Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery

New perspective for pathomechanism and clinical applications of animal toxins: Programmed cell death

Recent Advances in Chemical Control of CRISPR/Cas9 Genome Editing Technology

Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges

Functional Toxicogenomic Assessment of Triclosan in Human HepG2 Cells Using Genome-Wide CRISPR-Cas9 Screening

Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy

[High-throughput functional screening using CRISPR/Cas9 system].

Gene Silencing Through CRISPR Interference in Bacteria: Current Advances and Future Prospects

Toxicogenomics: A 2020 Vision.

Applications of CRISPR-Cas9 mediated genome engineering

Applications of CRISPR Technology in Studying Plant-Pathogen Interactions: Overview and Perspective